Five-year follow-up of left ventricular diastolic function in systemic sclerosis patients: Determinants of mortality and disease progression

Seminars in Arthritis and Rheumatism

Volumn 44, Issue 2, 2014, Pages 220-227

  Faludi, Réka ^a   Költo, Gyöngyvér ^b   Bartos, Barbara ^a   Csima, Georgina ^a   Czirják, László ^a   Komócsi, András ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Kaposi Mor Teaching Hospital   (Hungary)

Author keywords

Diastolic dysfunction; Disease progression; Follow up; Mortality; Myocardial fibrosis; Survival; Systemic sclerosis; Tissue doppler imaging

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HUMAN; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LEFT VENTRICULAR MASS INDEX; MALE; MAXIMAL LEFT ATRIAL VOLUME INDEX; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; SURVIVAL; SYSTEMIC SCLEROSIS; TISSUE DOPPLER IMAGING; AGED; CASE CONTROL STUDY; COMORBIDITY; LONGITUDINAL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; RISK FACTOR; SCLERODERMA, SYSTEMIC; SURVIVAL RATE;

AGED; CASE-CONTROL STUDIES; COMORBIDITY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RISK FACTORS; SCLERODERMA, SYSTEMIC; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84927522149     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2014.04.001     Document Type: Article

References (26)

1. Komócsi A., Vorobcsuk A., Faludi R., Pintér T., Lenkey Z., Költo G., et al. The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies. Rheumatology (Oxford) 2012, 51:1027-1036.
2. Faludi R., Komócsi A., Bozó J., Kumánovics G., Czirják L., Papp L., et al. Isolated diastolic dysfunction of right ventricle: stress-induced pulmonary hypertension. Eur Respir J 2008, 31:475-476.
3. Komócsi A., Pintér T., Faludi R., Magyari B., Bozó J., Kumánovics G., et al. Overlap of coronary disease and pulmonary arterial hypertension in systemic sclerosis. Ann Rheum Dis 2010, 69:202-205.
4. Allanore Y., Meune C., Vonk M.C., Airo P., Hachulla E., Caramaschi P., et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis 2010, 69:218-221.
5. Kahan A., Allanore Y. Primary myocardial involvement in systemic sclerosis. Rheumatology (Oxford) 2006, 45(Suppl 4):iv14-iv17.
6. Meune C., Avouac J., Wahbi K., Cabanes L., Wipff J., Mouthon L., et al. Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: a controlled study of 100 consecutive patients. Arthritis Rheum 2008, 58:1803-1809.
7. Meune C., Vignaux O., Kahan A., Allanore Y. Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies. Arch Cardiovasc Dis 2010, 103:46-52.
8. LeRoy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T.A., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-205.
9. Pavlicek M., Wahl A., Rutz T., de Marchi S.F., Hille R., Wustmann K., et al. Right ventricular systolic function assessment: rank of echocardiographic methods vs. cardiac magnetic resonance imaging. Eur J Echocardiogr 2011, 12:871-880.
10. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
11. Nagueh S.F., Appleton C.P., Gillebert T.C., Marino P.N., Oh J.K., Smiseth O.A., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009, 10:165-193.
12. Vinereanu D., Nicolaides E., Tweddel A.C., Fraser A.G. "Pure" diastolic dysfunction is associated with long-axis systolic dysfunction. Implications for the diagnosis and classification of heart failure. Eur J Heart Fail 2005, 7:820-828.
13. Hinchcliff M., Desai C.S., Varga J., Shah S.J. Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis. Clin Exp Rheumatol 2012, 30(2 Suppl 71):S30-S37.
14. Plazak W., Gryga K., Sznajd J., Tomkiewicz-Pajak L., Suchon E., Wilisowska J., et al. Diastolic heart dysfunction, increased pulmonary capillary wedge pressure and impaired exercise tolerance in patients with systemic sclerosis. Kardiol Pol 2011, 69:243-249.
15. Rosato E., Maione S., Vitarelli A., Giunta A., Fontanella L., de Horatio L.T., et al. Regional diastolic function by tissue Doppler echocardiography in systemic sclerosis: correlation with clinical variables. Rheumatol Int 2009, 29:913-919.
16. D'Alto M., Cuomo G., Romeo E., Argiento P., Iudici M., Vettori S., et al. Tissue Doppler imaging in systemic sclerosis: a 3-year longitudinal study. Semin Arthritis Rheum 2014, 43:673-680.
17. Shuai X.X., Chen Y.Y., Lu Y.X., Su G.H., Wang Y.H., Zhao H.L., et al. Diagnosis of heart failure with preserved ejection fraction: which parameters and diagnostic strategies are more valuable?. Eur J Heart Fail 2011, 13:737-745.
18. de Groote P., Gressin V., Hachulla E., Carpentier P., Guillevin L., Kahan A., et al. Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis. Ann Rheum Dis 2008, 67:31-36.
19. Akram M.R., Handler C.E., Williams M., Carulli M.T., Andron M., Black C.M., et al. Angiographically proven coronary artery disease in scleroderma. Rheumatology (Oxford) 2006, 45:1395-1398.
20. Ngian G.S., Sahhar J., Proudman S.M., Stevens W., Wicks I.P., Van Doornum S. Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis. Ann Rheum Dis 2012, 71:1980-1983.
21. Steen V.D., Medsger T.A. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007, 66:940-944.
22. Tyndall A.J., Bannert B., Vonk M., Airo P., Cozzi F., Carreira P.E., et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010, 69:1809-1815.
23. Douglas P.S. The left atrium: a biomarker of chronic diastolic dysfunction and cardiovascular disease risk. J Am Coll Cardiol 2003, 42:1206-1207.
24. Armstrong G.P., Whalley G.A., Doughty R.N., Gamble G.D., Flett S.M., Tan P.L., et al. Left ventricular function in scleroderma. Br J Rheumatol 1996, 35:983-988.
25. Maione S., Cuomo G., Giunta A., Tanturri de Horatio L., La Montagna G., Manguso F., et al. Echocardiographic alterations in systemic sclerosis: a longitudinal study. Semin Arthritis Rheum 2005, 34:721-727.
26. Gabrielli A., Avvedimento E.V., Krieg T. Scleroderma. N Engl J Med 2009, 360:1989-2003.